ROBECO INVESTMENT MANAGEMENT INC.

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

February 12, 2016

Accession Number

0001085146-16-003096

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →